|
Dr. Wardell has his own consulting firm, Wardell Associates International, LLC, in Princeton, NJ. A large part of his consulting includes solving problems in drug development, regulatory approval, and safety, for both large pharma companies and small startups. He spent 15 years in academic medicine (Clinical Pharmacology and Medicine) before entering the pharmaceutical industry, where he has spent 20 years in management positions in large pharmas and biotech, and in a large contract research organization. He testified as an expert in drug development in several congressional hearings. In addition to drug discovery and development and its contribution to medicine, his interests include clinical pharmacology, clinical trial methodology, drug safety, regulation, biotechnology, pharmacogenomics, and botanicals--topics on which he has published over one hundred scientific papers and four books. His pharmaceutical and biotechnology industry experience includes: President, Protein Engineering Corporation (now DYAX); Senior-VP, Drug Development, Parke-Davis; VP-Medical Director, Boehringer Ingelheim Pharmaceuticals; Senior Scientific Officer at Covance and Executive Director of the Covance Institute for Drug Development Sciences. Bill Wardell earned his M.A., Ph.D. (in pharmacology), and M.D. at the University of Oxford (UK), and was a Merck International Fellow in Clinical Pharmacology and Medicine under Dr. Louis Lasagna at the University of Rochester / Strong Memorial Hospital. | 